| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biochemistry and Biophysics |
INSERM U-524 and Laboratoire de Pharmacologie Antitumorale du Centre Oscar Lambret, IRCL, Lille 59045, France [J. K., A. L., N. W., C. M., C. B.], and Vanderbilt University, School of Medicine, Nashville, Tennessee 37232-0146 [N. O.]
TAS-103 is a DNA intercalating indeno-quinoline derivative that
stimulates DNA cleavage by topoisomerases. This synthetic drug has a
broad spectrum of antitumor activity against many human solid tumor
xenografts and is currently undergoing clinical trials. We investigated
the induction of apoptosis in human promyelocytic leukemia cells
treated with TAS-103. The treatment of proliferating human leukemia
cells for 24 h with various concentrations of the drug induces
significant variations in the mitochondrial transmembrane potential
(
mt) measured by flow cytometry using the
fluorochromes 3,3-dihexyloxacarbocyanine iodide, Mitotracker Red, and
tetrachloro-tetraethylbenzimidazolcarbocyanine iodide. The collapse of

mt is accompanied by a marked decrease of the
intracellular pH. Cleavage experiments with the substrates
N-acetyl-Asp-Glu-Val-Asp-pNA, poly(ADP-ribose)
polymerase, and pro-caspase-3 reveal unambiguously that caspase-3 is a
key mediator of the apoptotic pathway induced by TAS-103. Caspase-8 is
also cleaved, and the bcl-2 oncoprotein is underexpressed. Drug-induced
internucleosomal DNA fragmentation and the externalization of
phosphatidylserine residues in the outer leaflet of the plasma membrane
were also characterized. The cell cycle perturbations produced by
TAS-103 can be connected with the changes in 
mt. At
low concentrations (225 nM), the drug induces a marked
G2 arrest and concomitantly provokes an increase in the
potential of mitochondrial membranes. In contrast, treatment of the
HL-60 cells with higher drug concentrations (50 nM to 1
µM) triggers massive apoptosis and a collapse of

mt that is a signature for the opening of the
mitochondrial permeability transition pores. The discovery of a
correlation between the G2 arrest and changes in
mitochondrial membrane potential provides an important mechanistic
insight into the action of TAS-103.
This article has been cited by other articles:
![]() |
M. Yoshida, Y. Kabe, T. Wada, A. Asai, and H. Handa A New Mechanism of 6-((2-(Dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one Dihydrochloride (TAS-103) Action Discovered by Target Screening with Drug-Immobilized Affinity Beads Mol. Pharmacol., March 1, 2008; 73(3): 987 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Intasai, S. Mai, W. Kasinrerk, and C. Tayapiwatana Binding of multivalent CD147 phage induces apoptosis of U937 cells Int. Immunol., July 1, 2006; 18(7): 1159 - 1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, J. Wada, I. Hashimoto, J. Eguchi, A. Yasuhara, Y. S. Kanwar, K. Shikata, and H. Makino Therapeutic Approach for Diabetic Nephropathy Using Gene Delivery of Translocase of Inner Mitochondrial Membrane 44 by Reducing Mitochondrial Superoxide Production J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1090 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuoka, J. Wada, I. Hashimoto, Y. Zhang, J. Eguchi, N. Ogawa, K. Shikata, Y. S. Kanwar, and H. Makino Gene Delivery of Tim44 Reduces Mitochondrial Superoxide Production and Ameliorates Neointimal Proliferation of Injured Carotid Artery in Diabetic Rats Diabetes, October 1, 2005; 54(10): 2882 - 2890. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Torigoe, H. Izumi, T. Wakasugi, I. Niina, T. Igarashi, T. Yoshida, I. Shibuya, K. Chijiiwa, K.-i. Matsuo, H. Itoh, et al. DNA Topoisomerase II Poison TAS-103 Transactivates GC-Box-dependent Transcription via Acetylation of Sp1 J. Biol. Chem., January 14, 2005; 280(2): 1179 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Chen, X. Zhang, T. P. Singleton, and F. L. Kiechle Mitochondrial Membrane Potential Change Induced by Hoechst 33342 in Myelogenous Leukemia Cell Line HL-60 Ann. Clin. Lab. Sci., October 1, 2004; 34(4): 458 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. KLUZA, A. M. CLARK, and C. BAILLY Apoptosis Induced by the Alkaloid Sampangine in HL-60 Leukemia Cells: Correlation between the Effects on the Cell Cycle Progression and Changes of Mitochondrial Potential Ann. N.Y. Acad. Sci., December 1, 2003; 1010(1): 331 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lansiaux, F. Tanious, Z. Mishal, L. Dassonneville, A. Kumar, C. E. Stephens, Q. Hu, W. D. Wilson, D. W. Boykin, and C. Bailly Distribution of Furamidine Analogues in Tumor Cells: Targeting of the Nucleus or Mitochondria Depending on the Amidine Substitution Cancer Res., December 15, 2002; 62(24): 7219 - 7229. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pang, S. Wakabayashi, and M. Shigekawa Expression of Calcineurin B Homologous Protein 2 Protects Serum Deprivation-induced Cell Death by Serum-independent Activation of Na+/H+ Exchanger J. Biol. Chem., November 8, 2002; 277(46): 43771 - 43777. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Facompre, C. Carrasco, P. Colson, C. Houssier, J. D. Chisholm, D. L. Van Vranken, and C. Bailly DNA Binding and Topoisomerase I Poisoning Activities of Novel Disaccharide Indolocarbazoles Mol. Pharmacol., November 1, 2002; 62(5): 1215 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Torigoe, H. Izumi, H. Ishiguchi, H. Uramoto, T. Murakami, T. Ise, Y. Yoshida, M. Tanabe, M. Nomoto, H. Itoh, et al. Enhanced Expression of the Human Vacuolar H+-ATPase c subunit Gene (ATP6L) in Response to Anticancer Agents J. Biol. Chem., September 20, 2002; 277(39): 36534 - 36543. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mizutani, S. Tada-Oikawa, Y. Hiraku, S. Oikawa, M. Kojima, and S. Kawanishi Mechanism of Apoptosis Induced by a New Topoisomerase Inhibitor through the Generation of Hydrogen Peroxide J. Biol. Chem., August 16, 2002; 277(34): 30684 - 30689. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lansiaux, M. Facompre, N. Wattez, M.-P. Hildebrand, C. Bal, D. Demarquay, O. Lavergne, D. C. H. Bigg, and C. Bailly Apoptosis Induced by the Homocamptothecin Anticancer Drug BN80915 in HL-60 Cells Mol. Pharmacol., September 1, 2001; 60(3): 450 - 461. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |